Happy New Year 2024 to all our members and visitors! Our Forum is Now Back Online After Some Critical Upgrade- We Apologize for the inaccessibility Period! Thank You all. CORONAVIRUS safety tips from Admin! 1. Watch your hands with running water 2. Dont cough in your hands 3. Keep distance from people 4. Stay indoor if neccessary!! Stay safe !!! Dear Members,Do you know that naijacrux is fully programmed to serve you better, Do you know that you can share your favorite post on naijacrux with friends on twitter,facebook, googleplus,myspace and many more! To share post on naijacrux with friends and family on twitter, facebook,googleplus,myspace,and many more, scroll to the down page of the post, Click on the Social Icon You Want To Share On To Share.


Author Topic: Bill Gates Pledges $30 Million Push for Early Alzheimer's Diagnostics  (Read 1834 times)

0 Members and 1 Guest are viewing this topic.

Offline guruslodge

  • Global Moderator
  • Hero Member
  • *****
  • Posts: 1020
  • Karma: +0/-0
Loading...
 

Billionaire Bill Gates and Estée Lauder Cos chairman emeritus Leonard Lauder on Tuesday said they will award $30 million over three years to encourage development of new tests for early detection of Alzheimer’s disease.

For Microsoft co-founder Gates, launch of the Diagnostics Accelerator program follows an announcement in November of a personal investment of $50 million in the Dementia Discovery Fund, a venture capital fund aimed at bringing together industry and government to seek treatments for the brain-wasting disease.

The effort, Gates said, was fueled in part by his personal experience with family members struggling with Alzheimer’s.

The most common form of dementia, Alzheimer’s affects nearly 50 million people worldwide and is expected to rise to more than 131 million by 2050, according to Alzheimer’s Disease International.

Gates and Lauder provided seed money for the diagnostics collaboration through the Alzheimer’s Drug Discovery Foundation (ADDF), which was founded by Lauder. They will be joined by other philanthropists, including the Dolby family and the Charles and Helen Schwab Foundation.

Funding provided through the initiative will be open to scientists and clinicians globally working in academic settings, charities and biotechnology companies.

As a philanthropy vehicle, the ADDF Diagnostics Accelerator venture will invest in riskier projects that may not have immediate commercial return, the group said in a statement.

Drugmakers have poured billions of dollars into scores of failed attempts to produce a treatment that can arrest the ravages of Alzheimer’s, a fatal disease that robs people of their memories and ability to care for themselves.